
Glaxosmithkline India (GSK), one of the largest manufacturers of branded paracetamol in India, said it does not anticipate any supply shortages "at the moment" due to the Covid-19 outbreak in China.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2V3Y9hG
via
IFTTT
0 comments:
Post a Comment